ArticleAnnals of the rheumatic diseases2020

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.

Maximilian F Konig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.